Announcements Trials
Browse Landscape

Phase

Phase 2 14Phase 1 4Phase 1/2 3Phase NA 2Phase EARLY_PHASE1 1

Status

Completed 9Unknown 3Terminated 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Rectal Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 1

Interventions

Radiosurgery 28Magnetic Resonance Spectroscopy 25Blood Specimen Collection 20Radiotherapy 19Surveys and Questionnaires 18Exercise 16Early Intervention, Educational 16Methods 15Cyclophosphamide 15Surgical Procedures, Operative 14Standard of Care 14Radiotherapy, Intensity-Modulated 14Biopsy 13Acupuncture Therapy 12Interviews as Topic 11Cisplatin 11Filgrastim 10Educational Status 10Radiofrequency Ablation 9Magnetic Resonance Imaging 9Fluorodeoxyglucose F18 9fludarabine phosphate 8Radiation 8Gemcitabine 8X-Rays 7Sorafenib 7Practice Guidelines as Topic 7Granulocyte Colony-Stimulating Factor 7Colonoscopy 7Capecitabine 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Terminated × Gene Expression Profiling × Clear all
NCT01280643 2021-03-15

Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

Fox Chase Cancer Center

Phase NA Terminated
3 enrolled 8 charts
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00608595 2013-03-05

Celecoxib in Treating Patients With Early-Stage Rectal Cancer

Vanderbilt-Ingram Cancer Center

Phase NA Terminated
10 enrolled
Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡